The Disrupted Mitochondrial Quality Control Network: A Unifying Mechanism and Therapeutic Target for Chemotherapy-Induced Multi-Organ Toxicity
Open Access
Abstract
Chemotherapy remains a cornerstone of systemic cancer treatment, yet dose-limiting toxicities—cardiotoxicity, neurotoxicity, and nephrotoxicity—affect 40–80% of patients, interrupt 20–30% of treatment cycles, and double long-term mortality. We propose that these seemingly distinct organ toxicities converge on a single mechanism: selective disruption of the MQC network. MQC comprises five interdependent modules—biogenesis, dynamics, mitophagy, proteostasis, and the recently characterized migrasome-mediated mitocytosis—collectively maintaining ATP supply, redox balance, and Ca2+ homeostasis in high-demand tissues. Chemotherapeutics such as anthracyclines, platinum agents, and taxanes simultaneously repress PGC-1α-driven biogenesis, hyperactivate Drp1-mediated fission, impair autophagosome–lysosome fusion, and inhibit mitocytosis, triggering mitochondrial collapse, ROS overflow, and cell death. This first-in-field review delineates organ-specific MQC pathways and catalogs druggable interventions—including small molecules, natural products, and nano-delivery systems—that restore MQC checkpoints. We present an integrated “MQC disruption–multi-organ toxicity–targeted intervention” framework, identifying Drp1 hyperactivation, late-stage mitophagy arrest, and mitocytosis inhibition as core therapeutic nodes. Targeting these pathways offers a promising strategy to decouple anticancer efficacy from off-target toxicity, potentially enabling optimized dosing, reducing treatment discontinuation, and improving long-term prognosis. Most MQC-targeted agents, however, remain in preclinical or early-phase trials.Keywords
Funding Information
- Gansu Province Youth Talent Project (2025NQTD11)
- National Natural Science Foundation of China (8226150235)
- National Natural Science Foundation of China (82405224)
- Gansu Province Science and Technology Projects (22JR11RA122)
- Gansu Provincial Program for Young PhDs’ Integration into Enterprises and Industrial Parks (2026QB-062)
- Gansu Postdoctoral Fund
This publication has 219 references indexed in Scilit:
- Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Physical Fatigue Through the Perspective of ImmunosenescenceComprehensive Physiology, 2025
- Mitigating Doxorubicin‐Induced Cardiotoxicity and Enhancing Anti‐Tumor Efficacy with a Metformin‐Integrated Self‐Assembled NanomedicineAdvanced Science, 2025
- Phytochemicals Targeting Mitophagy to Treat Heart Diseases: Retrospective Insights and Prospective DirectionsPhytotherapy Research, 2025
- A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosisAdvanced Science, 2024
- Mitochondrial Dysfunction‐Evoked DHODH Acetylation is Involved in Renal Cell Ferroptosis during Cisplatin‐Induced Acute Kidney InjuryAdvanced Science, 2024
- Chemotherapy2023
- Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclinesCochrane Database of Systematic Reviews, 2022
- The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatinHealth Science Reports, 2022
- Doxorubicin‐Induced Cardiomyopathy in ChildrenComprehensive Physiology, 2019
- Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane2012